Company profile: BioCare Copenhagen
1.1 - Company Overview
Company description
- Provider of dietary supplements with microbial components for gastrointestinal problems, infections, and immune enhancement; offers medical nutrition, early life nutrition, pharma solutions, and nutrition improvement. Products include Humiome B2, supporting gut health by delivering a high percentage of vitamin B2 to the colon.
Products and services
- Dietary Supplements: BioCare Copenhagen engineers science-backed dietary products containing microbial components targeting gastrointestinal problems, infections, and immune enhancement, inspiring consumers to prioritize their health
- Humiome B2: A colon-targeted product supporting gut health by delivering a high percentage of vitamin B2 directly to the colon
- Medical Nutrition: BioCare Copenhagen architects special-needs-focused medical nutrition products engineered to support recovery and enhance quality of life for individuals with specific nutritional requirements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioCare Copenhagen
Seres Therapeutics
HQ: United States
Website
- Description: Provider of microbiome therapeutics, including VOWST, an FDA-approved oral microbiota-based therapy to prevent recurrent Clostridioides difficile infection in adults after antibacterial treatment; SER-155, an investigational oral microbiome therapeutic aimed at reducing gastrointestinal infections, bacteremia, and graft versus host disease in immunocompromised patients; and a platform to design, test, and manufacture bacterial consortia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seres Therapeutics company profile →
Kallyope
HQ: United States
Website
- Description: Provider of medicines developed using the science of gut-brain biology to transform human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kallyope company profile →
Infinant Health
HQ: United States
Website
- Description: Provider of infant gut microbiome solutions, offering Evivo Powder, a daily supplement for infants fed any amount of breast milk to establish a protective gut microbiome and support healthy immune function, and B. infantis EVC001, a bacterial strain discovered by Infinant Health and proven pivotal to infant immune health, particularly when combined with breast milk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infinant Health company profile →
Solarea Bio
HQ: United States
Website
- Description: Provider of microbial therapeutics and microbial-based solutions targeting chronic inflammation. Develops Defined Microbial Assemblage products combining probiotic microbes from fruits and vegetables with prebiotic fibers, advances medical foods, and creates synbiotics to protect against bone loss. Also offers licensing of its microbial-based technology, including a technology licensing agreement with ADM.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Solarea Bio company profile →
4D Pharma
HQ: United Kingdom
Website
- Description: Provider of live biotherapeutics, a novel class of drugs defined by the FDA as biological products containing a live organism, such as bacteria, applicable to the prevention, treatment or cure of disease; developer of MicroRx, a proprietary platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4D Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioCare Copenhagen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioCare Copenhagen
2.2 - Growth funds investing in similar companies to BioCare Copenhagen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioCare Copenhagen
4.2 - Public trading comparable groups for BioCare Copenhagen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →